Figure 1: OS in patients with... | American Society of Hematology

Figure 1:

Figure 1:. OS in patients with S-Creatinine >=177 μmol/L receiving bortezomib based treatment compared to the control group

OS in patients with S-Creatinine >=177 μmol/L receiving bortezomib based treatment compared to the control group

This Feature Is Available To Subscribers Only

Sign In or Create an Account